Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311379464> ?p ?o ?g. }
- W4311379464 endingPage "246" @default.
- W4311379464 startingPage "225" @default.
- W4311379464 abstract "Abstract: Alzheimer's Disease (AD), affecting a large population worldwide, is characterized by the old population's loss of memory and learning ability. Cholinergic deficiency is associated with AD, and various cholinesterase inhibitors have been developed to treat AD, including naturally-derived inhibitors, synthetic analogs, and hybrids. Acetylcholinesterase (AChE) has obtained a re-newed interest as a therapeutic target in Alzheimer's disease (AD) due to increased neural cells' function by increasing the concentration of acetylcholine. In this review, we reported the recent de-velopment of novel heterocyclic compounds such as coumarin-benzotriazole hybrids, carbazole de-rivatives, tacrine conjugates, N-benzyl-piperidine-aryl-acyl hydrazones hybrid, spiropyrazoline de-rivatives, coumarin-dithiocarbamate hybrids, etc., as AChE inhibitors for the treatment of Alz-heimer disease. All the bioactive compounds show an effect on different cells and interact simulta-neously with the catalytic active site (CAS) and peripheral anionic site (PAS) of AChE with a nar-row range of IC50 values from 0.4 nm to 88.21 μm using Ellman’s in vitro AChE assay method and show high BBB permeability in vitro. In addition, the in vitro fluorescence assay study using Am-plex Red assay kits revealed that all the compounds could inhibit self-induced β-amyloid (Aβ) ag-gregation with the highest inhibition range from 31.4 to 82%. Furthermore, most of the compounds show a low toxicity profile during in vivo studies. The results suggest that all the compounds consti-tute promising leads for the AChE targeted approach for Alzheimer’s disease." @default.
- W4311379464 created "2022-12-25" @default.
- W4311379464 creator A5009147075 @default.
- W4311379464 creator A5034765635 @default.
- W4311379464 creator A5060320229 @default.
- W4311379464 creator A5062327802 @default.
- W4311379464 creator A5065852427 @default.
- W4311379464 creator A5084015464 @default.
- W4311379464 date "2023-02-01" @default.
- W4311379464 modified "2023-10-09" @default.
- W4311379464 title "A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer’s Disease" @default.
- W4311379464 cites W1021164303 @default.
- W4311379464 cites W1804425206 @default.
- W4311379464 cites W1940331911 @default.
- W4311379464 cites W1964528690 @default.
- W4311379464 cites W1968682237 @default.
- W4311379464 cites W1972844855 @default.
- W4311379464 cites W1994414156 @default.
- W4311379464 cites W1999756573 @default.
- W4311379464 cites W2004713321 @default.
- W4311379464 cites W2008014544 @default.
- W4311379464 cites W2010499668 @default.
- W4311379464 cites W2011098517 @default.
- W4311379464 cites W2015331537 @default.
- W4311379464 cites W2015408700 @default.
- W4311379464 cites W2021661129 @default.
- W4311379464 cites W2026970282 @default.
- W4311379464 cites W2028992719 @default.
- W4311379464 cites W2031998093 @default.
- W4311379464 cites W2035895733 @default.
- W4311379464 cites W2041570449 @default.
- W4311379464 cites W2041791799 @default.
- W4311379464 cites W2049771698 @default.
- W4311379464 cites W2052455126 @default.
- W4311379464 cites W2054106674 @default.
- W4311379464 cites W2074010037 @default.
- W4311379464 cites W2089223747 @default.
- W4311379464 cites W2089731588 @default.
- W4311379464 cites W2093345349 @default.
- W4311379464 cites W2093374391 @default.
- W4311379464 cites W2114163624 @default.
- W4311379464 cites W2124096646 @default.
- W4311379464 cites W2137777161 @default.
- W4311379464 cites W2142587255 @default.
- W4311379464 cites W2158984087 @default.
- W4311379464 cites W2170085655 @default.
- W4311379464 cites W2201202471 @default.
- W4311379464 cites W2304410534 @default.
- W4311379464 cites W2310209739 @default.
- W4311379464 cites W2311545879 @default.
- W4311379464 cites W2553024664 @default.
- W4311379464 cites W2560925171 @default.
- W4311379464 cites W2571360328 @default.
- W4311379464 cites W2575879719 @default.
- W4311379464 cites W2584090676 @default.
- W4311379464 cites W2594162701 @default.
- W4311379464 cites W2597990638 @default.
- W4311379464 cites W2605975439 @default.
- W4311379464 cites W2741310665 @default.
- W4311379464 cites W2749530071 @default.
- W4311379464 cites W2758125332 @default.
- W4311379464 cites W2759730036 @default.
- W4311379464 cites W2773981221 @default.
- W4311379464 cites W2788957403 @default.
- W4311379464 cites W2790307818 @default.
- W4311379464 cites W2790720134 @default.
- W4311379464 cites W2792470204 @default.
- W4311379464 cites W2792609242 @default.
- W4311379464 cites W2793377695 @default.
- W4311379464 cites W2794014030 @default.
- W4311379464 cites W2794546769 @default.
- W4311379464 cites W2801505389 @default.
- W4311379464 cites W2802986815 @default.
- W4311379464 cites W2891367558 @default.
- W4311379464 cites W2891710083 @default.
- W4311379464 cites W2900638116 @default.
- W4311379464 cites W2900730595 @default.
- W4311379464 cites W2904170142 @default.
- W4311379464 cites W2914810900 @default.
- W4311379464 cites W2942400557 @default.
- W4311379464 cites W2944155053 @default.
- W4311379464 cites W2945154057 @default.
- W4311379464 cites W2949334322 @default.
- W4311379464 cites W2949609387 @default.
- W4311379464 cites W2951219679 @default.
- W4311379464 cites W2953616125 @default.
- W4311379464 cites W2969268714 @default.
- W4311379464 cites W2990773547 @default.
- W4311379464 cites W2997306738 @default.
- W4311379464 cites W3002640076 @default.
- W4311379464 cites W3006398177 @default.
- W4311379464 cites W3006968676 @default.
- W4311379464 cites W3022249552 @default.
- W4311379464 cites W3023013291 @default.
- W4311379464 cites W3047910726 @default.
- W4311379464 cites W3092032238 @default.
- W4311379464 cites W3119757183 @default.
- W4311379464 cites W3152913705 @default.